Citation Impact
Citing Papers
Mycoplasma pneumoniae triggering the Guillain‐Barré syndrome: A case‐control study
2016
Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity
2007
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria
2013
Clinical features in Guillain–Barré syndrome with anti-Gal-C antibody
2013
No evidence of a link between influenza vaccines and Guillain–Barre syndrome–associated antiganglioside antibodies
2011
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Anti-PMP22 antibodies in patients with inflammatory neuropathy
2000
Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcome
1998 Standout
Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
2008
Recurrences, vaccinations and long‐term symptoms in GBS and CIDP
2009
Guillain-Barré syndrome
2010
Different IVIG Glycoforms Affect In Vitro Inhibition of Anti-Ganglioside Antibody-Mediated Complement Deposition
2014
Susceptibility to Guillain–Barré syndrome is associated to polymorphisms of CD1 genes
2006
Guillain-Barre Syndrome following Primary Cytomegalovirus Infection: A Prospective Cohort Study
2011
Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain–Barré syndrome and Miller Fisher syndrome
2012
Chronic inflammatory demyelinative polyneuropathy
2013
Guillain-Barré syndrome
2016 Standout
Familial Guillain-Barré syndrome: First Indian report
2012
Binational outbreak of Guillain–Barré syndrome associated withCampylobacter jejuniinfection, Mexico and USA, 2011
2013
IgG Fc Glycosylation in Human Immunity
2019
Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study
2014
O-Pair Search with MetaMorpheus for O-glycopeptide characterization
2020 StandoutNobel
Subclass IgG to motor gangliosides related to infection and clinical course in Guillain–Barré syndrome
2008
Guillain-Barre syndrome subtypes related to Campylobacter infection
2011
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
2018 Standout
Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model
2008
Blood γδ T cells, Campylobacter jejuni, and GM1 titers in Guillain–Barré syndrome
2004
Guillain–Barré Syndrome
2012 Standout
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy
2016 Standout
Tissue-resident macrophages
2013 Standout
The immunobiology of Guillain‐Barré syndromes
2005
Contrasting immune responses mediate Campylobacter jejuni-induced colitis and autoimmunity
2013
Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies
2010
Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome
2005
Streptococcal IdeS: therapeutic potential for Guillain–Barré syndrome
2015
Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome
2021
Siglecs at the Host–Pathogen Interface
2020
Genetic polymorphisms of macrophage-mediators in Guillain–Barré syndrome
2007
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Corticosteroids for Guillain-Barré syndrome
2006
Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health
2017
Biological roles of glycans
2016 Standout
Multi-Ethnic Study of Atherosclerosis: Objectives and Design
2002 Standout
Pre‐ and postsynaptic blockade of neuromuscular transmission by Miller–Fisher syndrome IgG at mouse motor nerve terminals
1998
Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A review
2009
Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy
2005
Glycolipid antigens and autoantibodies in autoimmune neuropathies
2013
Miller Fisher anti-GQ1b antibodies: ?-Latrotoxin-like effects on motor end plates
1999
Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome
1996
Outcome and its predictors in Guillain–Barré syndrome
2012
Revealing the human mucinome
2022 StandoutNobel
Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera
2003
Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination
2004
The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders
2014
Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction
2011
Glycosylation in health and disease
2019
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal
2001
An open label clinical trial of complement inhibition in multifocal motor neuropathy
2011
Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies
2004
Guillain-Barre syndrome in Asia
2013
Gut flora in health and disease
2003 Standout
Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
2015
Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy
2004
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice
2009 StandoutNobel
Guillain-Barré syndrome
1998
Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction
2009
Myocarditis
2000 Standout
The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice
2009
Non-motor features of Parkinson disease
2017 Standout
Cytokines, Inflammation, and Pain
2007 Standout
Anti-GQ1b Ganglioside Antibody in Peripheral Nervous System Disorders
2004
Erythropoietin Ameliorates Rat Experimental Autoimmune Neuritis by Inducing Transforming Growth Factor-Beta in Macrophages
2011
Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome
2000 Standout
Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS)
2013
Peripheral neuropathies and anti-glycolipid antibodies
2002
Monoclonal antibodies raised against Guillain-Barré syndrome–associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations
1999
Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barr� syndrome
1997
Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis
2014
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Mast cell dipeptidyl peptidase I mediates survival from sepsis
2004
Cross-Reactive Antibodies against Gangliosides and Campylobacter jejuni Lipopolysaccharides in Patients with Guillaln-Barre or Miller Fisher Syndrome
1997
Haemophilus influenzae infection and Guillain-Barre syndrome
2000
Guillain-Barr?? Syndrome
2004
Pathogenesis of Guillain–Barré syndrome
1999
The inflammatory reflex
2002 StandoutNature
The interplay between Siglecs and sialylated pathogens
2014
Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barr� syndrome: A reappraisal
1999
Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease
1996
Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity
2009 Standout
Diversity of Lipopolysaccharide Structures inCampylobacter jejuni
1997
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
Mast cells in the development of adaptive immune responses
2005 Standout
The risk of Guillain–Barré syndrome following infection with Campylobacter jejuni
1999
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Relationship ofCampylobacterToxigenicity In Vitro to the Development of Postinfectious Irritable Bowel Syndrome
2001
Gut microbiota and malnutrition
2016
Guillain-Barré syndrome
2005 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time
2003
Gut microbiota in human metabolic health and disease
2020 Standout
Autoimmune responses in peripheral nerve
1996
Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system
2004
Glycoproteomics
2022 StandoutNobel
Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes
2014
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain–Barre syndrome
2000
Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh
2010
Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
1993 Standout
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Enhanced, Sialoadhesin-Dependent Uptake of Guillain-Barré Syndrome-Associated Campylobacter jejuni Strains by Human Macrophages
2013
Protein Malnutrition in Children: Advances in Knowledge in the Last Ten Years
1971
Genetics of Guillain‐Barré syndrome (GBS ) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP ): current knowledge and future directions
2014
Cyclic Adenosine Monophosphate and Alteration of Chinese Hamster Ovary Cell Morphology: a Rapid, Sensitive In Vitro Assay for the Enterotoxins of Vibrio cholerae and Escherichia coli
1974 StandoutNobel
Intravenous immunoglobulin for Guillain-Barré syndrome
2014
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
2003 Standout
Guillain-Barr� syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies
1995
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
2016 Standout
Markers for Guillain‐Barré syndrome with poor prognosis: a multi‐center study
2017
Streptococcus pneumoniae Infections in 47 Hematopoietic Stem Cell Transplantation Recipients
2007
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
2005 Standout
Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
2020 StandoutNobel
Pain in Guillain-Barré syndrome
2010
Campylobacter jejuni Lipooligosaccharides Modulate Dendritic Cell-Mediated T Cell Polarization in a Sialic Acid Linkage-Dependent Manner
2011
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Molecular mimicry: Can epitope mimicry induce autoimmune disease?
1997
Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain–Barre syndrome
1999
Beyond Neurons: Evidence That Immune and Glial Cells Contribute to Pathological Pain States
2002
Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry
2001
Enterotoxigenic Intestinal Bacteria in Tropical Sprue
1973
Pain in acquired inflammatory demyelinating polyneuropathies
2016
Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain–Barré syndrome (GBS)
1997
Sialoadhesin Promotes Rapid Proinflammatory and Type I IFN Responses to a Sialylated Pathogen, Campylobacter jejuni
2012
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Inflammatory infiltrates in the spinal cord of patients with Guillain-Barr� syndrome
2003
Intravenous immunoglobulin therapy for Miller Fisher syndrome
2007
IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barre syndrome
1999
Mimics and chameleons in Guillain–Barré and Miller Fisher syndromes
2014
Paraparetic Guillain-Barré syndrome
2014
The Guillain–Barré syndrome: a true case of molecular mimicry
2003
Lipopolysaccharides from Campylobacter jejuni O:41 Strains Associated with Guillain-Barre Syndrome Exhibit Mimicry of GM 1 Ganglioside
1998
Gastrointestinal flora of children with protein—calorie malnutrition
1972
Intestinal Microflora
1971
Duodenal microflora
1975
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Multifaceted Roles of Autophagy in Flavivirus-Host Interactions
2018
Guillain-Barré syndrome associated with preceding hepatitis E virus infection
2014
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
2015
Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome
2016
Interaction of Polymorphonuclear Neutrophils with Escherichia Coli
1978 StandoutNobel
Immunoglobulin G Fc N-glycosylation in Guillain-Barré syndrome treated with intravenous immunoglobulin
2014
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Intestinal flora in health and disease
1984
Infection and Atherosclerosis
1999
Acute undifferentiated human diarrhea in the tropics
1971
Prediction of respiratory insufficiency in Guillain‐Barré syndrome
2010
Works of Bart C. Jacobs being referenced
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome
2010
COMBINATORIAL GLYCOARRAY DETECTS DIVERSE NEW ANTIBODY SPECIFICITIES IN GUILLAIN-BARRE SYNDROME
2011
International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain‐Barré syndrome
2017
Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA
2005
Inter‐laboratory validation of an ELISA for the determination of serum anti‐ganglioside antibodies
1999
IgG Fc N-Glycosylation in Guillain–Barré Syndrome Treated with Immunoglobulins
2014
Sialylation of Campylobacter jejuni Lipo-Oligosaccharides: Impact on Phagocytosis and Cytokine Production in Mice
2012
Selective Digestive Tract Decontamination Decreases Time on Ventilator in Guillain–Barré Syndrome
2011
A clinical prognostic scoring system for Guillain-Barré syndrome
2007
Dysfunction at the motor end‐plate and axon membrane in Guillain–Barré syndrome: A single‐fiber EMG study
2003
Serum anti‐GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome
1995
Limb motor nerve dysfunction in Miller Fisher syndrome
2013
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic
2020
Serum IgG levels as biomarkers for optimizing IVIg therapy in CIDP
2011
Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain‐Barré syndrome
2009
Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry
1995
Guillain‐Barré Syndrome: Multifactorial Mechanisms versus Defined Subgroups
1997
Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding
2003
Zika Virus Infection and Guillain–Barré Syndrome in Three Patients from Suriname
2016
Innate I mmunity to C ampylobacter jejuni in G uillain‐B arré S yndrome
2015
Mannose-Binding Lectin Contributes to the Severity of Guillain-Barre Syndrome
2006
High mortality from Guillain‐Barré syndrome in Bangladesh
2017
Sialylation of Campylobacter jejuni Endotoxin Promotes Dendritic Cell–Mediated B Cell Responses through CD14-Dependent Production of IFN-β and TNF-α
2013
The occurrence of Guillain-Barre syndrome within families
2004
Mortality in Guillain-Barré syndrome
2013
TLR4-Mediated Sensing of Campylobacter jejuni by Dendritic Cells Is Determined by Sialylation
2010
Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome
2013
BACTERIAL CONTAMINATION OF THE UPPER SMALL BOWEL IN TROPICAL SPRUE
1969
Association of Albumin Levels With Outcome in Intravenous Immunoglobulin–Treated Guillain-Barré Syndrome
2016
Skewed Fc Glycosylation Profiles of Anti-proteinase 3 Immunoglobulin G1 Autoantibodies from Granulomatosis with Polyangiitis Patients Show Low Levels of Bisection, Galactosylation, and Sialylation
2015
Health‐related quality of life in Guillain‐Barré syndrome patients: a systematic review
2014
Early recognition of poor prognosis in Guillain-Barré syndrome
2011